Recurrent, metastatic disease represents the most frequent cause of death for patients with
thyroid cancer, and radioactive iodine (RAI) remains a mainstay of therapy for these patients …

Thyroid nodules are extremely common and can be detected by sensitive imaging in more
than 60% of the general population. They are often identified in patients without symptoms …

Background: Papillary thyroid microcarcinoma (PTMC) typically carries an excellent
prognosis regardless of the treatment option pursued. Radiofrequency ablation (RFA) for …

Background Since the early 1980s, papillary thyroid cancer (PTC) incidence rates and the
prevalence of obesity, a risk factor for PTC, have increased substantially in the United …

Abstract The guidelines Thyroid Cancer 2022 are prepared based on previous Polish
recommendations updated in 2018. They consider international guidelines—American …

Context The risk stratification of patients with differentiated thyroid cancer (DTC) is crucial in
clinical decision making. The most widely accepted method to assess risk of …

Abstract Background The eighth edition American Joint Committee on Cancer tumor-node-
metastasis staging for well-differentiated thyroid cancers, no longer considers “minimal” …

Thyroid cancer is the most common endocrine malignancy with almost one million people
living with thyroid cancer in the United States. Although early-stage well-differentiated …

Background: The morbidity of papillary thyroid carcinoma (PTC) is primarily related to
locoregional recurrences and distant metastases. The definition of minimal extrathyroidal …

Background Extrathyroidal extension is a major risk factor for poor prognosis in papillary
thyroid cancer. However, the effect of different degrees of extrathyroidal extension on …